The aim of this randomized, placebo-controlled trial is to investigate the effects of propolis supplementation on some blood biochemical parameters in people with type II diabetes. Sixty patients with type II diabetes are of both sexes to participate in the study. Eligible patients will randomly be divided into two groups using a table of random numbers. Participants in the intervention group received three capsules of 500 mg of propolis for two months and the control group received placebo. Fasting blood glucose, lipid profile,oxidized LDL, fructosamine, glycosylated hemoglobin, insulin, insulin resistance, antioxidant capacity, glutathione peroxidase, dismutase (SOD),Catalase, inflammatory markers TNFα and CRP, interleukin 6 and 17 and liver enzymes aspartate aminotransferase and alanine aminotransferase in two groups before the intervention and at the end of the study measured and compared.